LAVA Therapeutics NV
NASDAQ:LVTX
LAVA Therapeutics NV
Tax Provision
LAVA Therapeutics NV
Tax Provision Peer Comparison
Competitive Tax Provision Analysis
Latest Figures & CAGR of Competitors
Company | Tax Provision | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LAVA Therapeutics NV
NASDAQ:LVTX
|
Tax Provision
-$279k
|
CAGR 3-Years
-91%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Tax Provision
$1.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-44%
|
CAGR 10-Years
N/A
|
|
Uniqure NV
NASDAQ:QURE
|
Tax Provision
-$3.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-57%
|
CAGR 10-Years
N/A
|
|
argenx SE
XBRU:ARGX
|
Tax Provision
$32.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merus NV
NASDAQ:MRUS
|
Tax Provision
-$4.7m
|
CAGR 3-Years
-118%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Tax Provision
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LAVA Therapeutics NV's Tax Provision?
Tax Provision
-279k
USD
Based on the financial report for Dec 31, 2023, LAVA Therapeutics NV's Tax Provision amounts to -279k USD.
What is LAVA Therapeutics NV's Tax Provision growth rate?
Tax Provision CAGR 3Y
-91%
Over the last year, the Tax Provision growth was -12%. The average annual Tax Provision growth rates for LAVA Therapeutics NV have been -91% over the past three years .